Minerva Neurosciences (NERV) Shares Outstanding (2013 - 2026)

Minerva Neurosciences (NERV) has 14 years of Shares Outstanding (Entity) data on file, last reported at $43.8 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 526.9% year-over-year to $43.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.8 million (up 526.9% YoY) and the FY2025 annual result came in at $8.5 million, up 21.02% from the prior year.
• Shares Outstanding (Entity) advanced to $43.8 million in Q1 2026, from $8.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $43.8 million in Q1 2026 to a low of $1.5 million in Q3 2025.
• A 5-year average of $8.3 million and a median of $7.0 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2025 — Shares Outstanding (Entity) sank 78.79% — and 2026, when it jumped 526.9%.
• Tracing NERV's Shares Outstanding (Entity) over 5 years: stood at $5.3 million in 2022, then soared by 30.96% to $7.0 million in 2023, then changed by 0.0% to $7.0 million in 2024, then climbed by 21.02% to $8.5 million in 2025, then soared by 418.01% to $43.8 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $43.8 million (Q1 2026), $8.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.